Publications by authors named "Barbara Schuler"

Claim this Profile
K
Kaempferol Is an Anti-Inflammatory Compound with Activity towards NF-κB Pathway Proteins.
Onat Kadioglu, Janine Nass, Mohamed E M Saeed, Barbara Schuler, Thomas Efferth

Anticancer Res· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mesothelin-CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy.
Raffit Hassan, Charles Schweizer, Kun F Lu, Barbara Schuler, Alan T Remaley

Lung Cancer· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for anti-inflammatory activity of 12 Arnica (Asteraceae) species assessed by inhibition of NF-kappaB and release of human neutrophil elastase.
Catarina Ekenäs, Anna Zebrowska, Barbara Schuler, Tobias Vrede, Katarina Andreasen

Planta Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer.
Gregory D Leonard, Maurice A Wright, Mary G Quinn, Suzanne Fioravanti, Nancy Harold, Barbara Schuler

BMC Cancer· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.
Maurice A Wright, Geraldine Morrison, Pengxin Lin, Gregory D Leonard, Dat Nguyen, Barbara Schuler

Clin Cancer Res· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.
Xiao-Du Guo, Nancy Harold, M Wasif Saif, Barbara Schuler, Eva Szabo

Cancer Chemother Pharmacol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-escalating and pharmacological study of oxaliplatin in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study.
Chris H Takimoto, Scot C Remick, Sunil Sharma, Sridhar Mani, Ramesh K Ramanathan, Barbara Schuler

J Clin Oncol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypersensitivity and idiosyncratic reactions to oxaliplatin.
Rebecca R Thomas, Mary G Quinn, Barbara Schuler, Jean L Grem

Cancer· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of two weekly schedules of oral eniluracil given with fluorouracil and leucovorin on the duration of dihydropyrimidine dehydrogenase inhibition.
Bruce Keith, Xiao-Du Guo, Suzanne Zentko, Nancy Harold, Barbara Schuler

Clin Cancer Res· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis